Guggenheim Capital’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,994
Closed -$1.23M 1945
2022
Q3
$1.23M Buy
28,994
+23,712
+449% +$1M 0.01% 1043
2022
Q2
$285K Buy
5,282
+286
+6% +$15.4K ﹤0.01% 1793
2022
Q1
$321K Buy
4,996
+495
+11% +$31.8K ﹤0.01% 1847
2021
Q4
$302K Buy
4,501
+284
+7% +$19.1K ﹤0.01% 1868
2021
Q3
$289K Buy
+4,217
New +$289K ﹤0.01% 1923
2021
Q2
Sell
-6,696
Closed -$463K 2203
2021
Q1
$463K Buy
6,696
+170
+3% +$11.8K ﹤0.01% 1749
2020
Q4
$424K Sell
6,526
-4,161
-39% -$270K ﹤0.01% 1702
2020
Q3
$505K Buy
10,687
+3,200
+43% +$151K ﹤0.01% 1443
2020
Q2
$352K Buy
7,487
+1,820
+32% +$85.6K ﹤0.01% 1553
2020
Q1
$253K Sell
5,667
-2,346
-29% -$105K ﹤0.01% 1589
2019
Q4
$467K Sell
8,013
-13,398
-63% -$781K ﹤0.01% 1619
2019
Q3
$1.29M Sell
21,411
-3,453
-14% -$207K 0.01% 1210
2019
Q2
$1.39M Sell
24,864
-2,178
-8% -$122K 0.01% 1200
2019
Q1
$1.51M Buy
27,042
+4,467
+20% +$249K 0.01% 1198
2018
Q4
$1.02M Buy
22,575
+13,350
+145% +$602K 0.01% 1376
2018
Q3
$608K Buy
9,225
+3,090
+50% +$204K ﹤0.01% 1876
2018
Q2
$394K Sell
6,135
-4,000
-39% -$257K ﹤0.01% 2069
2018
Q1
$562K Sell
10,135
-693
-6% -$38.4K ﹤0.01% 2333
2017
Q4
$518K Sell
10,828
-1,601
-13% -$76.6K ﹤0.01% 2350
2017
Q3
$629K Buy
12,429
+1,290
+12% +$65.3K ﹤0.01% 2307
2017
Q2
$607K Buy
11,139
+1,717
+18% +$93.6K ﹤0.01% 2342
2017
Q1
$397K Buy
9,422
+574
+6% +$24.2K ﹤0.01% 2460
2016
Q4
$380K Sell
8,848
-16,244
-65% -$698K ﹤0.01% 2512
2016
Q3
$1.04M Sell
25,092
-2,140
-8% -$88.4K ﹤0.01% 2064
2016
Q2
$1.09M Sell
27,232
-906
-3% -$36.1K ﹤0.01% 1999
2016
Q1
$948K Sell
28,138
-13,758
-33% -$464K ﹤0.01% 2086
2015
Q4
$1.42M Buy
41,896
+33,434
+395% +$1.13M ﹤0.01% 1868
2015
Q3
$252K Buy
+8,462
New +$252K ﹤0.01% 2660
2013
Q3
Sell
-15,430
Closed -$231K 3023
2013
Q2
$231K Buy
+15,430
New +$231K ﹤0.01% 2626